<< [Back to News Releases]

CareFusion Updates Labeling For ChloraPrep® Products

Important Information For Clinicians About Dry Time Directions

Nov 12, 2013

SAN DIEGO, Nov. 12, 2013 /PRNewswire/ -- CareFusion (NYSE:CFN), a leading global medical technology company, today announced it has received FDA approval to update labeling with reduced dry times as part of the directions for use on certain of its ChloraPrep® products.

The reduced dry times apply to a number of CareFusion ChloraPrep products used in skin preparation, including Sepp®, Frepp®, Single and Triple Swabsticks.  These applicators are no longer labeled for electrocautery procedures and have a reduced dry time on dry surgical sites of 30 seconds and a dry time on moist surgical sites of one minute.

Labeling for the ChloraPrep® 3mL applicators has also been updated to include dry time changes to 30 seconds for dry sites and one minute for moist sites for procedures not using an ignition source. The required dry times for procedures that use an ignition source remain unchanged at a minimum of three minutes on hairless skin and and up to one hour in hair.

Labeling for the ChloraPrep® 10.5mL and 26mL applicators remains unchanged.

To view the complete updated labels and other important information about ChloraPrep®, visit http://www.carefusion.com/medical-products/infection-prevention/skin-preparation/labels.aspx. Additional questions about the updated labeling should be directed to CareFusion Customer Support at 1-800-523-0502.

About CareFusion Corporation
CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops industry-leading technologies including Alaris® infusion pumps, Pyxis® automated dispensing and patient identification systems, AVEA®, AirLife® and LTV® series ventilation and respiratory products, ChloraPrep® products, MedMined® services for data mining surveillance, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs approximately 15,000 people across its global operations. More information may be found at www.carefusion.com.

(Logo: http://photos.prnewswire.com/prnh/20100706/CAREFUSIONLOGO)

SOURCE CareFusion Corporation

For further information: Media, Troy Kirkpatrick, (858) 617-2361, troy.kirkpatrick@carefusion.com, Investors, Jim Mazzola, (858) 617-1203, jim.mazzola@carefusion.com